Cargando…

A network‐based predictive gene expression signature for recurrence risks in stage II colorectal cancer

The current criteria for defining the recurrence risks of stage II colorectal cancer (CRC) are not robust; therefore, we aimed to explore novel gene signatures to predict recurrence risks and to reveal the underlying mechanisms of stage II CRC. First, the gene expression profiles of 124 patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Wen‐Jing, Wang, Hai‐Bo, Wang, Wen‐Da, Bai, Peng‐Yu, Lu, Hong‐Xia, Sun, Chang‐He, Liu, Zi‐Shen, Guan, Ding‐Kun, Yang, Guo‐Wang, Zhang, Gan‐Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943157/ https://www.ncbi.nlm.nih.gov/pubmed/31724326 http://dx.doi.org/10.1002/cam4.2642

Ejemplares similares

Correlation between immune signature and high‐density lipoprotein cholesterol level in stage II/III colorectal cancer
por: Wang, Yun, et al.
Publicado: (2019)

Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer
por: Wang, De‐shen, et al.
Publicado: (2019)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

An immune‐related prognostic signature for predicting breast cancer recurrence
por: Tian, Zelin, et al.
Publicado: (2020)

MiRNA-574-3p inhibits cell progression by directly targeting CCND2 in colorectal cancer
por: Li, Wen-Cui, et al.
Publicado: (2019)

Comparative genomic signatures in young and old Chinese patients with colorectal cancer
por: Wang, Fei, et al.
Publicado: (2021)

Colorectal cancer cells promote osteoclastogenesis and bone destruction through regulating EGF/ERK/CCL3 pathway
por: Zi-chen, Gong, et al.
Publicado: (2020)

Relationship of HER2 Alteration and Microsatellite Instability Status in Colorectal Adenocarcinoma
por: Qiu, Miao‐Zhen, et al.
Publicado: (2021)

Identification of survival-related alternative splicing signatures in acute myeloid leukemia
por: Zhang, Biyu, et al.
Publicado: (2021)

Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma
por: Liu, Jie, et al.
Publicado: (2020)

Predicted the P2RX7 rs3751143 polymorphism is associated with cancer risk: a meta-analysis and systematic review
por: Wang, Bi-jun, et al.
Publicado: (2021)

Construction of immune‐related risk signature for renal papillary cell carcinoma
por: Wang, Zhongyu, et al.
Publicado: (2018)

A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer
por: Xin, Cheng, et al.
Publicado: (2023)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer
por: Xu, Ke, et al.
Publicado: (2020)

Trends in survival of patients with stage I/II Burkitt lymphoma in the United States: A SEER database analysis
por: Liu, Ze‐Long, et al.
Publicado: (2019)

A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sources
por: Zhao, Wenyuan, et al.
Publicado: (2016)

Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways
por: Wan, Mao-lin, et al.
Publicado: (2020)

A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings
por: Ao, Lu, et al.
Publicado: (2018)

MiR-27b-3p promotes migration and invasion in colorectal cancer cells by targeting HOXA10
por: Yang, Xiangling, et al.
Publicado: (2019)

miR-125 inhibits colorectal cancer proliferation and invasion by targeting TAZ
por: Yang, Meiyuan, et al.
Publicado: (2019)

Proteomic characteristics reveal the signatures and the risks of T1 colorectal cancer metastasis to lymph nodes
por: Zhuang, Aojia, et al.
Publicado: (2023)

Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer
por: Su, Wei-Chih, et al.
Publicado: (2021)

Mismatch repair status between primary colorectal tumor and metastatic tumor, a retrospective consistent study
por: Wang, Zheng, et al.
Publicado: (2019)

A circRNA signature predicts postoperative recurrence in stage II/III colon cancer
por: Ju, Huai‐Qiang, et al.
Publicado: (2019)

High-throughput proteomics profiling-derived signature associated with chemotherapy response and survival for stage II/III colorectal cancer
por: Ye, Shu-Biao, et al.
Publicado: (2023)

Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Immunohistochemistry‐Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer
por: Li, Yaqi, et al.
Publicado: (2020)

Predictive impact of the inflammation‐based indices in colorectal cancer patients with adjuvant chemotherapy
por: Tao, Yong, et al.
Publicado: (2018)

Low NLRP3 expression predicts a better prognosis of colorectal cancer
por: Shi, Feng, et al.
Publicado: (2021)

The local treatment modalities in FIGO stage I‐II small‐cell carcinoma of the cervix are determined by disease stage and lymph node status
por: Zhou, Juan, et al.
Publicado: (2016)

Circulating lncRNA DANCR as a potential auxillary biomarker for the diagnosis and prognostic prediction of colorectal cancer
por: Shen, Xianjuan, et al.
Publicado: (2020)

A molecular signature for the prediction of recurrence in colorectal cancer
por: Wang, Lisha, et al.
Publicado: (2015)

Tumour stage and gender predict recurrence and second primary malignancies in head and neck cancer: a multicentre study within the INHANCE consortium
por: Leoncini, Emanuele, et al.
Publicado: (2018)

A 12-immune cell signature to predict relapse and guide chemotherapy for stage II colorectal cancer
por: Tian, Xianglong, et al.
Publicado: (2020)

Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinoma
por: Xiao, Liang, et al.
Publicado: (2019)

Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis
por: Ye, Zu‐Lu, et al.
Publicado: (2019)

An immune, stroma, and epithelial–mesenchymal transition‐related signature for predicting recurrence and chemotherapy benefit in stage II–III colorectal cancer
por: Cai, Du, et al.
Publicado: (2023)

Recurrent patterns after postoperative radiotherapy for early stage endometrial cancer: A competing risk analysis model
por: Ren, Kang, et al.
Publicado: (2021)

A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy
por: Liang, Jie‐ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4ng8r4g1c8hi2rviv5t9pu9hhc